Predictive Oncology Inc.
13F holders, Q4 2024 (December 31)16holders +1
3new positions
3sold out
$0.82avg. 13F price*
At the end of Q4 2024, 16 institutions reported holding Predictive Oncology Inc. in their 13F filings, up 1 from Q3 2024. 3 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($58K), Geode Capital Management, LLC ($42K) and Csenge Advisory Group ($25K).
- Company
- Predictive Oncology Inc.
- CUSIP
- 74039M309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $38K |
| Exits | 3 | $16K |
All 13F filers, Q3 2024 → Q4 2024: 63,256 shares bought and 24,395 shares sold, net +38,861 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Vanguard Group Inc. | 0.00% | No change | 71,307 | $58K |
| Geode Capital Management, LLC | 0.00% | Reduce -1.3% | 51,206 | $42K |
| Csenge Advisory Group | 0.00% | Add +130.8% | 30,000 | $25K |
| Jane Street Group, LLC | 0.00% | New | 26,241 | $22K |
| XTX Topco Ltd | 0.00% | New | 19,965 | $16K |
| State Street Corp. | 0.00% | No change | 13,837 | $11K |
| Two Sigma Investments, LP | 0.00% | Reduce -12.3% | 11,018 | $9K |
| Carnegie Mellon University | 0.01% | No change | 10,358 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -31.5% | 4,864 | $4K |
| Wells Fargo & Company | 0.00% | No change | 1,000 | $820 |
| Osaic Holdings, Inc. | 0.00% | No change | 425 | $347 |
| PSI Advisors, LLC | 0.00% | No change | 399 | $327 |
| Bank of America Corp. | 0.00% | No change | 51 | $42 |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 50 | $41 |
| SBI Securities Co., Ltd. | 0.00% | — | 14 | $11 |
| Royal Bank of Canada | 0.00% | No change | 50 | $0 |
"% of holder's portfolio" is PREDICTIVE ONCOLOGY INC's weight in each manager's 13F, not the share of Predictive Oncology Inc. the manager owns.